医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.

广告
第一作者: Bohdan,Nosyk
第一单位: Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada.;Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
作者单位: Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada.;Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada. [1] Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada. [2] Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom. [3] British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.;Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. [4] Department of Epidemiology and Department of Statistics, University of California, Loa Angeles. [5] Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada.;School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. [6] Center for Health Decision Science and Departments of Epidemiology and Health Policy and Management, Harvard University T.H. Chan School of Public Health, Boston, Massachusetts.;Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL-University for Health Sciences and Technology, Tirol, Austria.;Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. [7] Centre hospitalier de l'Université de Montréal, CRCHUM, Montreal, Quebec, Canada.;Département de médecine de famille et de médecine d'urgence, Université de Montréal, Montreal, Quebec, Canada. [8] Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada. [9] Department of Psychiatry, University of Pennsylvania, Philadelphia. [10] School of Public Health, Oregon Health & Science University-Portland State University, Portland, Oregon.;Section of Addiction Medicine, Oregon Health & Science University, Portland. [11] Department of Statistics and Actuarial Sciences, Simon Fraser University, Burnaby, British Columbia, Canada. [12] Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.;Department of Statistics and Actuarial Sciences, Simon Fraser University, Burnaby, British Columbia, Canada. [13] Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. [14] Department of Economics, Simon Fraser University, Burnaby, British Columbia, Canada. [15]
DOI 10.1001/jama.2024.16954
PMID 39418046
发布时间 2025-04-18
提交
  • 浏览0
JAMA

JAMA

2024年332卷21期

1822-1831页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷